Skip to content
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Clinical Topics
View All
Depression
Neurologic
Anxiety
Schizophrenia
Trauma
Psychopharmacology
Bipolar
Tardive Dyskinesia
OCD
Addiction
View All
Columns
View All
ASCP Corner
Clinical & Practical Psychopharmacology
Rounds General Hospital
Academic Highlights
Banner Alzheimer’s Institute
Focus on Geriatric Psychiatry
Charles M. Beasley, Jr.
JCP
Original Research
Analysis of the QTc Interval During Olanzapine Treatment of Patients With Schizophrenia and Related Psychosis
JCP
Article
Cardiac Safety Parameters of Olanzapine: Comparison With Other Atypical and Typical Antipsychotics
JCP
Original Research
Changes in Adverse Events Reported by Patients During 6 Months of Fluoxetine Therapy
JCP
Original Research
Early Symptomatic Worsening During Treatment With Fluoxetine in Major Depressive Disorder: Prevalence and Implications
JCP
Original Research
Efficacy, Adverse Events, and Treatment Discontinuations in Fluoxetine Clinical Studies of Major Depression: A Meta-Analysis of the 20-mg/day Dose
JCP
Article
Efficacy of Olanzapine: An Overview of Pivotal Clinical Trials
JCP
Original Research
Extrapyramidal Symptoms and Tolerability of Olanzapine Versus Haloperidol in the Acute Treatment of Schizophrenia
JCP
Original Research
Predictors of Relapse During Fluoxetine Continuation or Maintenance Treatment of Major Depression
JCP
Article
Safety of Olanzapine